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 Abstract
Background: Ash (Fraxinus excelsior) is an important source of allergenic pollen in temperate areas of Europe. Profilin and polcalcin are 
2 important panallergens involved in cross-reactivity between different sources.
Objective: To clone and produce Fra e 2 (profilin) and Fra e 3 (polcalcin) as recombinant proteins and evaluate their immunological properties 
using the natural forms obtained from ash pollen.
Methods: Total RNA from ash pollen was used as a template to obtain the specific complementary DNA (cDNA) sequences of the 2 panallergens. 
The cDNA-encoding sequences were cloned into the pET11b expression vector and used to transform BL21 (DE3) Escherichia coli cells. Proteins 
were expressed, purified by chromatography, and characterized structurally by circular dichroism, mass spectrometry, and immunologically by 
western blot and ELISA using profilin and polcalcin polyclonal antibodies and human sera from ash pollen–sensitized patients.
Results: Profilin and polcalcin amino acid sequences from ash pollen showed a high degree of identity with homologous allergens from 
different sources. The cDNA-encoding allergen sequences were expressed as nonfusion recombinant proteins and purified to homogeneity. 
Secondary structure values were similar to those obtained from other members of these families. Allergenic properties of the recombinant 
allergens were observed to be equivalent to those of the natural counterparts of F excelsior pollen.
Conclusions: Fra e 2 and Fra e 3 recombinant allergens might be used in clinical diagnosis to determine profilin- and polcalcin-specific 
IgE levels present in the sera of ash pollen–sensitized patients, thus facilitating the finding of the sensitizing source in areas with complex 
sensitization profiles.
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 Resumen
Antecedentes: El polen de fresno (Fraxinus excelsior) es una importante fuente alergénica en zonas cálidas de Europa. La profilina y 
polcalcina son 2 panalérgenos implicados en reactividad cruzada.
Objetivos: Clonar y producir Fra e 2 (profilina) y Fra e 3 (polcalcina) como alérgenos recombinantes. Comparar sus propiedades inmunológicas 
con sus formas naturales del polen de fresno.
Métodos: El RNA total de polen de fresno se utilizó como molde para obtener los cDNAs específicos de ambos panalérgenos. Dichos cDNAs 
se clonaron en el vector de expresión pET11b y se transformaron células de Escherichia coli BL21(DE3). Las proteínas se caracterizaron 
mediante dicroísmo circular, espectrometría de masas, inmunodetección en membrana y ELISA utilizando anticuerpos policlonales frente 
a profilina y polcalcina y sueros de pacientes alérgicos al polen de fresno.
Resultados: Las secuencias de aminoácidos de la profilina y polcalcina de polen de fresno presentaban una identidad de secuencia elevada 
con alérgenos homólogos. Dichos alérgenos se expresaron como proteínas recombinantes independientes y se purificaron a homogeneidad. 
Los valores de estructura secundaria fueron similares a los de otros miembros de estas familias. Las propiedades alergénicas de los alérgenos 
recombinantes resultaron ser equivalentes a los de sus homólogos naturales del polen.
Conclusiones: Los alérgenos recombinantes Fra e 2 y Fra e 3 podrían usarse en diagnóstico clínico para determinar los niveles de IgE 
específicos para profilina y polcalcina en los sueros de los pacientes sensibilizados a polen de fresno, facilitando así la identificación de 
la fuente sensibilizante en áreas donde los pacientes presentan perfiles alergénicos complejos.
Palabras clave: Polen de fresno. Panalérgenos. Polcalcina. Profilina. Alérgeno recombinante.
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Introduction
The Oleaceae family is composed of approximately 400 
species. From an allergenic perspective, the most representative 
genus is Olea. Olea europaea (olive tree) is the second most 
common allergenic pollen in Mediterranean countries and the 
most common one in some large Spanish regions [1-4].
Ash (Fraxinus excelsior), another Oleaceae species, is 
mainly distributed throughout central Europe. Due to the 
widespread use of this tree as a source of wood, ash pollen has 
become an important source of allergens. Furthermore, given 
the high structural similarity between members of the Oleaceae 
family, these pollens are good candidates for studying cross-
reactivity processes [5]. To date, the presence of the allergens 
profilin, polcalcin, and Fra e 1 (a member of the Ole e 1–like 
family) have been described in F excelsior, but only Fra e 1 
has been characterized [5-7].
Profilin and polcalcin are known panallergens involved in 
cross-reactivity processes. They are small acidic proteins with 
molecular masses of 14 to 15 kDa and 9 kDa, respectively. 
Profilins are actin-binding proteins that regulate microfilament 
dynamics and mediate changes in polymerization in the 
microtubule cytoskeleton; they are also implicated in multiple 
signaling pathways, including those involving the Ena/VASP 
protein family [8]. Polcalcins, by contrast, belong to a 2 EF-
hand Ca2+-binding protein family and are involved in signaling 
processes, neuronal exocytosis, and pollen tube growth [9,10]. 
Both profilins and polcalcins have been described as 
panallergens in several pollen sources such as Betula 
verrucosa, Chenopodium album, and O europaea [7,9,11-
13]. Profilin panallergens have also been identified in foods 
and latex [14]. Both allergens are highly conserved among 
species and their amino acid sequences share a high degree 
of sequence identity with their counterparts in other allergenic 
sources (60%-90% for polcalcins and >75% for profilins). 
This accounts for the high level of cross-reactivity observed 
between members of the same family.
Profilin has been reported as a major allergen in pollen 
and food sources such as C Album and Cucumis melo, 
respectively [15,16], and in populations polysensitized to 
olive [13] or grass [17] pollens. Polcalcins are described as 
minor allergens in most of the sources analyzed but they still 
recruit a high percentage of specific IgE, ranging from 10% 
to 40% in allergic patients. Irrespective of their designation 
as major or minor allergens, both profilins and polcalcins are 
important markers of polysensitization, and at least in the case 
of profilins, previous sensitization to aeroallergens from pollens 
results in susceptibility to subsequent exposure to certain food 
counterparts, triggering oral allergy syndrome [18]. Indeed, 
sensitization to latex profilin has been reported to occur 
through primary sensitization to pollen or food allergens [19]. 
Polcalcins are involved in processes that occur during pollen 
germination. They have only been described in pollen grains, 
and accordingly have not been associated with pollen-food 
cross-reactivity [20].
In the present study we describe the recombinant 
expression and characterization of profilin and polcalcin 
panallergens from ash pollen. Our findings could facilitate 
the standardization of these allergens in extracts, improve 
component-resolved diagnosis of allergy to pollens from the 
Oleaceae family [21], and facilitate the design of effective 
treatments for polysensitized patients. The improvement of 
current diagnostic and treatment approaches is particularly 
important in areas in which individuals are exposed to multiple 
pollen types due to the overlap of different allergenic sources, 
which hampers patient diagnosis [17,22]. 
Methods
Plasmids and Cells
A TOPO-TA Cloning kit (Invitrogen) was used to obtain 
partial and full complementary (c) DNA-encoding sequences 
from Fra e 2 and Fra e 3 according to the manufacturer´s 
instructions. cDNA sequences were subcloned into the pET11b 
plasmid (Novagen) and used to transform Escherichia coli 
DH5α F΄ cells (Invitrogen). The recombinant proteins were 
then expressed in BL21 (DE3) cells (Agilent Technologies).
Food and Pollen Protein Extracts
Pollens from the indicated species were purchased from 
Allergon (Ängelholm). Pollen protein extracts were obtained 
by saline extraction as described previously [23]. The indicated 
protein extracts from nuts and fruits were also obtained as 
previously described [24].
Sera and Antibodies
Twenty-five patients from Strasbourg in France who 
were sensitized to ash pollen, as demonstrated by prick test, 
with specific IgE to ash pollen extract between class 1 and 
6 as determined by the CAP-RAST method (Amersham 
Pharmacia Biotech), with no migratory background to or from 
Mediterranean areas, and with ash pollen as a primary Oleaceae 
sensitizer, were recruited from the pulmonology department of 
Hôpital Lyautey (Hôpitaux Universitaires de Strasbourg). This 
randomly selected patient population displayed a similar level 
of Fra e 1 positivity to that described in previously published 
results [7,25], ie, they had demonstrated ash pollinosis and 
no bias to any specific allergens. All patients and nonatopic 
controls gave written informed consent. The protocols used 
for experimental work with mice were approved by the ethics 
committee of the Complutense University in Madrid, Spain, 
and the methodology relating to the use of human sera was 
approved by the ethics committee of Hôpital Lyautey in 
Strasbourg, France.
Rabbit polyclonal antisera against profilin Ole e 
2 (Ole e 2 pAb) or polcalcin Ole e 3 (Ole e 3 pAb) from 
O europaea pollen were generated in response to weekly 
injections (100 µg) of the allergen in complete Freund´s 
adjuvant. The production of these antibodies was supervised 
by staff at the animal facility at the Fundación Jiménez Díaz 
in Madrid, Spain, and performed in accordance with Spanish 
legislation and the guidelines of the ethics committee of 
Fundación Jiménez Díaz and Complutense University. 
Horseradish peroxidase-labeled goat anti-rabbit polyclonal 
IgG was purchased from Bio-Rad and mouse monoclonal anti-
human IgE was kindly donated by ALK-Abelló. Horseradish 
peroxidase-labeled goat anti-mouse pAb was purchased from 
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Pierce Chemical Co and horseradish peroxidase-labeled rabbit 
anti-mouse pAb was acquired from Dako.
Cloning and Recombinant Expression of Fra e 2 and 
Fra e 3
Total RNA from ash pollen was isolated as previously 
described [6] and used as a template to obtain cDNA by reverse 
transcription using the SMART RACE cDNA amplification 
kit in accordance with the manufacturer´s instructions (BD 
Biosciences/Clontech). Amplification of specific sequences 
from Fra e 2 and Fra e 3 was performed using degenerate 
oligonucleotides spanning the different sequences of previously 
described profilin and polcalcin allergens and a nonspecific 
primer (Universal Primer Mix, UPM) included in the kit.
The 2 proteins were cloned following a 2-step process. An 
initial polymerase chain reaction (PCR) round was performed with 
the UPM primer and the following degenerate oligonucleotides: 
5´-atacatATGTCNTGGCARRCNTAYGT-3´, encoding MSW 
S/A YV for Fra e 2 (NdeI restriction site underlined); and 
5´-atgaattcTTARAANATYTTNGCNACRTCYTT–3´, encoding 
KDVAK I/M F for Fra e 3 (EcoRI restriction site underlined). Next, 
the cDNA of Fra e 2 was cloned in a second round of PCR using the 
same degenerate sense primer and the antisense oligonucleotide 
5´-CTCATTGANCAGGGCCTGTAGCTCGAGTCC-3´, 
encoding LIDQGL, whose sequence was obtained from the 
sequencing of the first PCR round. For Fra e 3, the second 
round of PCR was performed using the previously obtained 
cDNA and the following specific sense and antisense primers, 
respectively:5´-atacatATGGCCGACGATCCACAGGAA
GT-3´ (MADDPQE;NdeI restriction site is underlined) and 
5´-aaagaattcctaGAAGATTTTTGCAACATCCTTGAC-3´ 
(VKDVAKIF; EcoRI restriction site is underlined), deduced 
from the previously obtained cDNA sequence. Both cDNA 
sequences were cloned into PCR2.1 (Invitrogen) and then 
digested with NdeI and EcoRI and subcloned into the pET11b 
plasmid (pET11b/Frae2.1 and pET11b/Frae3). E coli DH5α 
F΄ cells were transformed to expand these plasmids. Next, 
the recombinant constructs were used to transform E coli 
BL21(DE3) cells to express the allergens as recombinant 
proteins.
E coli BL21(DE3) transformed cells were induced with 0.4 
mM isopropyl-β-thiogalactoside at 37ºC for 4 hours and then 
centrifuged at 6000 g and 4ºC for 20 minutes. The cell pellets 
were resuspended in 20 mM ammonium bicarbonate (AB) 
containing 1 mM phenylmethylsulfonyl fluoride and lysed by 
3 cycles of freezing in liquid N2 and thawing at 42ºC. Debris 
was removed after centrifugation at 12 000 g for 20 minutes at 
4ºC and the supernatant containing the recombinant proteins 
was collected and lyophilized.
Purification of rFra e 2 and rFra e 3
The first step of the purification of both Fra e 2 and Fra e 
3 consisted of size-exclusion chromatography in a Sephadex 
G-50 medium column (39 x 5.75 cm) equilibrated in 0.2 M AB 
[pH 8.0]. For the purification of Fra e 3, fractions containing the 
recombinant protein were then loaded onto a DEAE-cellulose 
column and eluted with an ionic strength gradient ranging from 
0.1 to 0.5 M AB [pH 8.0]. Both recombinant proteins were then 
separately purified to homogeneity in a final step using reverse-
phase high-performance liquid chromatography (HPLC) in a 
Nucleosil C18 column with an acetonitrile gradient in 0.1% 
trifluoroacetic acid. All the chromatographic stages of Fra e 
2 and Fra e 3 protein purification were visualized by 17% 
SDS-PAGE in the absence of 2-mercapthoethanol according 
to standard procedures.
Structural Characterization and Sequence Analysis 
Predictions
Purified recombinant proteins were lyophilized and 
reconstituted in 50 mM sodium phosphate [pH 7.5] at a 
concentration of 200 µg/mL to record the far-UV CD spectra 
using a JASCO J-715 spectropolarimeter. CDNN CD spectra 
deconvolution software (Applied Photophysics) was used 
to determine the composition of the secondary structure. 
The experimental molecular mass was determined by mass 
spectrometry using a Bruker Reflex IV MALDI-TOF apparatus 
(Bruker-Franzer Analytic). The theoretical molecular masses 
corresponding to the sequences obtained by cloning were 
calculated using the ProtParam tool [26]. 
The homology of the polcalcin and profilin sequences 
obtained were analyzed using the Basic Local Alignment 
Search Tool of the National Center for Biotechnology 
Information [27] and sequences aligned using the GeneDoc 
software (http://www.nrbsc.org/). Modeling of the 3D structure 
of Fra e 2 and Fra e 3 was accomplished using the homology-
modeling server of the Swiss Institute of Bioinformatics [28], 
using Bet v 2 (PDB: 1cqa) and Che a 3 (PDB: 2opo) as 
templates for profilin [29]and polcalcin [30], respectively.
Immunological Characterization
After SDS-PAGE, the proteins were transferred to 
nitrocellulose membranes (Amersham Biosciences) and 
immunostained with polyclonal antibodies against Ole e 2 
(1:10 000) or Ole e 3 (1:5000), or with individual human sera 
from either ash pollen-sensitized patients or nonatopic controls 
(diluted 1:10), and then incubated with mouse monoclonal 
anti-human IgE. The membranes were then incubated with 
the corresponding peroxidase-labeled secondary antibodies. 
For the immunoblotting inhibition assays, Ole e 2 pAb or 
Ole e 3 pAb, or a pool of sera (n=5) were preincubated with 
phosphate buffer solution, and 1 or 5 µg of purified proteins 
were used as inhibitors. Finally, proteins were visualized 
using the chemiluminescent ECL Western blotting reagent 
(Amersham Biosciences).
Indirect ELISA was performed in triplicate in 96-well 
plates coated with 0.1 µg of purified recombinant protein. 
Assays were performed using individual human sera (1:10), 
a pool of 5 human sera (1:10), or polyclonal antibodies 
against Ole e 2 or Ole e 3 (1:10000 and 1:5000, respectively), 
previously adsorbed to various protein extracts as inhibitors (20 
or 200 µg). Binding of human IgE was detected by incubation 
with mouse monoclonal anti-human IgE (1:5000) followed by 
horseradish peroxidase-labeled goat anti-mouse Ig (1:2500). 
Absorbance was measured at 492 nm in an iMark microplate 
absorbance reader (Bio-Rad) after color production with the 
peroxidase substrate o-phenylenediamine (Sigma-Aldrich). 
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Mean absorbance values of over 0.1 were considered positive, 
and the percentage of inhibition was calculated using the 
following formula: inhibition (%) = [1-(absorbance at 492 nm 
with inhibitor/absorbance at 492 nm without inhibitor)] x 100.
Results
Cloning, Recombinant Production, and Purification 
of Ash Profilin and Polcalcin
Natural profilin and polcalcin were detected by 
immunoblotting of ash pollen protein extract with specific 
polyclonal antisera directed against profilin or polcalcin 
(Figure 1). Profilin appeared as a group of multiple bands of 
approximately 14 kDa and polcalcin appeared as a 10-kDa band.
cDNA sequences of profilin and polcalcin form F excelsior 
were obtained by PCR as described in the Methods section. 
After cloning and sequencing, 2 different DNA sequences 
were obtained for Fra e 2 and 3 for Fra e 3 (Figure 2A 
and B). Fra e 2.1 and 2.2 were composed of 402 and 399 
nucleotides (134 and 133 amino acids), respectively, while 
the 3 polcalcin isoforms were composed of 252 nucleotides 
(84 amino acids) each. Fra e 2.1 showed a high degree of 
sequence identity with plant-related profilins, while the 
DNA sequence of Fra e 2.2 was identical to that previously 
described for Amaranthaceae profilin [31]. Fra e 2.1 was thus 
selected for recombinant expression. The 3 DNA sequences 
obtained for Fra e 3 exhibited 6 silenced nucleotide changes 
with no modifications to their amino acid sequences. The 
only amino acid sequence deduced from the 3 isoforms is 
shown in Figure 2B. Comparison of Fra e 2.1 with Ole e 2 
revealed high sequence identity (96%) and similarity (99%). 
CBS Profilin
pAb
Polcalcin
pAb
116.0
66.0
45.0
35.0
25.0
18.4
14.4
10.0
kDa
Figure 1. Identification of natural profilin and polcalcin proteins in the 
Fraxinus excelsior pollen protein extract using polyclonal antisera (pAb) 
raised against olive pollen profilin or polcalcin allergens. In total, 50 
µg of total protein extract were separated by SDS-PAGE and stained 
with Coomassie Blue (CBS) or alternatively transferred to nitrocellulose 
membranes. Molecular weight markers are shown.
Moreover, identity and similarity scores of 71% to 85% and 
85% to 92% were obtained when Fra e 2.1 was compared 
with allergenic profilins from other sources, including those 
from unrelated families such as C album and B verrucosa, 
and from foods such as Arachis hypogea, Capsicum annuum, 
and Lycopersicum esculentum (Figure 2A). Similar findings 
were observed when Fra e 3 was compared with polcalcins 
from both related species such as O europaea (91%/97%) and 
Syringa vulgaris (85%/94%) and unrelated families such as B 
verrucosa, C album, Brassica napus, and Nicotianata bacum, 
with sequence identity and similarity values ranging from 61% 
to 81% and 82% to 92%, respectively (Figure 2B).
The selected cDNA-encoding sequences were cloned 
into the pET11b plasmid and used to transform BL21 (DE3) 
E coli cells for recombinant expression of the proteins. The 
production of the recombinant allergen was visualized by SDS-
PAGE. Fra e 2 and Fra e 3 were detected in the soluble fraction 
after bacterial lysis, with the highest yield obtained after 4 
hours of induction at 37ºC (Figure 3A). Two chromatographic 
steps were required for the purification of rFra e 2 and 3for 
rFra e 3. Although the proteins appeared to be homogeneous 
by SDS-PAGE, small amounts of contaminants were removed 
in a final chromatographic step, in both cases consisting of 
reverse-phase HPLC with an acetonitrile gradient (Figure 3B 
and C). For both proteins, this procedure rendered about 10 
mg of recombinant protein per liter of cell culture.
Molecular Characterization of Fra e 2 and Fra e 3
Experimental molecular masses of 14261.8 and 9242.1 Da 
were determined by mass spectrometry for rFra e 2 and rFra 
e 3, respectively (Figure 4A). These values differed from the 
respective theoretical molecular masses of 117.4 and 87.3 Da, 
probably due to the processing of the N-terminal methionine 
by the bacterial machinery in both recombinant proteins.
Analysis of the CD spectra revealed correct folding of the 
2 proteins. β-Sheet content in rFra e 2 and α-helix content in 
rFra e 3 were higher than that described in previous reports of 
the secondary structures of the corresponding resolved crystal 
structures (Figure 4B) [29,30].
Immunological Characterization of Ash Pollen 
Panallergens
Antigenic validation of the recombinant proteins was 
achieved by IgG immunoblotting inhibition experiments 
using natural profilin and polcalcin contained in the pollen 
protein extract (Figure 4C). rFra e 3completely inhibited IgG 
binding to natural polcalcin, while rFra e 2 induced 85% of 
IgG binding to natural profilin; in both cases 5 µg of each 
recombinant protein was used as an inhibitor. These results 
indicate the equivalence of both recombinant proteins to the 
natural forms present in pollen.
IgE binding to both recombinant proteins was tested by 
ELISA using sera from 25 randomly obtained ash pollen–
sensitized patients from Strasbourg, France (Figure 5A) [7,25]. 
According to the selection criteria, this cohort should be 
representative of patients with ash pollinosis, with no bias 
towards any specific allergen. This experiment revealed that 
52% and 16% of the sensitized patients possessed specific IgE 
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to rFra e 2 and rFra e 3, respectively. Median values of 0.175 
and 0.619 were obtained for the 15 sera reactive to rFra e 2 
and the 4 sera reactive to rFra e 3, respectively.
Three individual sera and a nonatopic control were tested 
by immunoblotting using rFra e 2 and rFra e 3 (Figure 5B), 
revealing specific IgE binding to the recombinant proteins. 
The validation of rFra e 2 and rFra e 3 against their natural 
counterparts was confirmed by immunoblotting inhibition 
assays of ash pollen extract using a pool of sera from patients 
allergic to each allergen and the recombinant proteins as 
inhibitors (Figure 5C). The recombinant forms resulted in 
complete inhibition of IgE binding to the natural profilin and 
polcalcin present in the F excelsior pollen protein extract.
Finally, IgE cross-reactivity of ash pollen profilin and 
polcalcin was analyzed in ELISA inhibition experiments 
b)
a)
using a pool of sera from ash pollen-sensitized patients and 
pollen and plant-derived food extracts (200 mg) as inhibitors 
(Table). The protein integrity of polcalcin in pollen and 
profilin in pollen and plant-derived food extracts was tested 
before being used in subsequent experiments (data not 
shown). For ash pollen profilin, IgE binding inhibition of 
50% to 70% was observed, except in the cases of tomato (L. 
esculentum), peanut (A. hypogea), and Artemisia vulgaris 
extracts, for which values of over 20% were observed. Small 
differences in IgE binding to pollen profilin were observed 
when pollen (mean [SD] inhibition, 69% [15%]) and plant-
derived foods (58% [17%]) extracts were used as inhibitors. 
For ash pollen polcalcin, IgE-binding inhibition values of 
50% to85% were observed, with 38% inhibition detected 
for A vulgaris.
Figure 2. Comparison of the amino acid sequences of profilin and polcalcin from related and unrelated allergenic sources. A, Alignment of amino acid 
sequences of Fra e 2 isoforms with pollen and food profilins (top); 3D-modeling of Fra e 2 (bottom). In orange, highly variable region; blue, actin-binding 
site; green, IP3-binding site and yellow, poly-L-proline-binding site. B, Alignment of Fra e 3 amino acid sequence with pollen polcalcins (top); 3D-modeling 
of Fra e 3 (dimer) (bottom). In orange, highly variable region; red, calcium-binding site; and blue, calcium ion. Percentages of identity and similarity are 
shown in each case in comparison with Fra e 2.1 (Accession number KC920922) and Fra e 3 (KC920923), respectively.
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Discussion
Ash tree is the main source of allergenic pollen in temperate 
areas of Europe. In these regions, allergies to ash pollen have 
gone largely unnoticed because of the overlapping flowering 
periods of ash tree and B verrucosa [4], with ash pollination 
naturally preceding birch pollination [32].Thus, the diagnosis 
of sensitization to both birch and ash and of polysensitization 
in general is quite complex and very often not established. 
Panallergens are families of ubiquitous proteins with close 
Figure 3. Recombinant production and purification of Fra e 2 and Fra e 3; 
17% SDS-PAGE with Coomassie Blue staining (CBS) of supernatant (Sp) 
and pellet (Pt) obtained after cell lysis at different induction times (A). 
Last step of purification consisted of reversed-phase high-performance 
liquid chromatography with an acetonitrile gradient for rFra e 2 (B) 
and rFra e 3 (c). The line in each chromatogram highlights the fractions 
pooled for each protein. Pooled fractions containing the recombinant 
proteins purified at homogeneity (0.5 µg) were run in 17% SDS-PAGE 
with CBS or alternatively transferred to nitrocellulose membranes and 
immunostained with the corresponding polyclonal antibody (pAb) (right 
panel). Molecular weight markers are shown.
Figure 4. Molecular and immunological characterization of rFra e 2 
and rFra e 3. A, Mass spectrometry in arbitrary units. B, CD spectra and 
percentages of secondary structure obtained by deconvolution. C, IgG-
binding inhibition assays by immunoblotting with the corresponding 
polyclonal antisera raised against olive pollen profilin or polcalcin to 50 
µg of total ash pollen protein extract using 1 or 5 µg of the recombinant 
purified proteins as inhibitors. (-), without inhibitor. Molecular weight 
markers are shown.
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structural similarities involved in cross-reactivity processes. 
These allergenic molecules are responsible for the majority of 
diagnostic errors in allergic patients. Although further studies 
are required to determine the relevance of some of these 
molecules (eg, profilins) as inducers of allergic symptoms, 
these proteins constitute important tools for allergy diagnosis 
given their involvement in cross-reactivity reactions. IgE 
reactivity to profilin is associated with multiple pollen 
sensitizations and pollen-food syndromes [33]. Moreover, as 
polcalcin is a pollen-specific protein, its allergenic relevance 
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has been exclusively associated with multiple pollen 
sensitizations, and not with food allergies [34]. 
It has been previously reported that panallergens from 
different sources do not exhibit complete immunological 
equivalence [35]. Thus, although sensitization can be diagnosed 
using any member of a family, specific immunotherapy could 
be improved by using the specific allergen against which a 
patient is actually sensitized [35,36]. Moreover, in addition 
to antibodies, immunotherapy involves T lymphocytes, 
which mediate distinct T-cell and antibody isotype responses 
to minimal amino acid differences in allergen isoforms. 
Therefore, the identification, cloning, and production of 
allergen isoforms from different allergenic sources are essential 
for their use in personalized desensitization protocols. 
The panallergens analyzed in this study—profilins and 
polcalcins—are highly conserved proteins, and are thus 
involved in cross-reactivity processes between different 
sources. Panallergens enhance the allergenic character of 
different sources and increase the likelihood of the unexpected 
challenge (burst) of allergic symptoms in individuals in 
certain geographical locations with high concentrations of 
other pollens. For example, sensitization to Fra e 2 and Fra e 
3 through F excelsior pollen in individuals living in northern 
and central Europe elicits allergic reactions on exposure to 
O europaea pollen, which is mainly distributed in southern 
Mediterranean Europe [37-39], where ash is rare. Importantly, 
the presence of specific IgE against these molecules in the 
serum of allergic patients leads to multiple sensitization 
processes to different sources, including food allergens and 
contact allergens (eg, latex) in the case of profilins and other 
pollens in the case of polcalcins.
The prevalence of 2 recombinant panallergens was 52% 
and 16% for profilin and polcalcin, respectively. The IgE-
binding frequency for profilin indicated a role as a major 
allergen in ash-sensitized patients, which is consistent 
with previous findings in selected populations of allergic 
patients [15,16,40]. However, the IgE-binding frequency of 
polcalcin is not affected by other homologous allergens or by 
environmental pollen levels; it is considered a minor allergen 
in all populations studied, including the F excelsior–allergic 
population from Strasbourg analyzed in the present study. 
Remarkably, median ELISA values revealed that despite its 
low prevalence, Fra e 3 can recruit more IgE than Fra e 2 in 
ash pollen–sensitized patients.
The allergens presented here were immunologically 
validated against their natural counterparts using i) polyclonal 
antisera raised against olive pollen profilin and polcalcin and 
ii) a pool of sera from allergic patients. Inhibition experiments 
revealed that the recombinant profilin was unable to completely 
inhibit IgG binding to the natural profilin present in the extract, 
probably due to the presence of other isoforms recognized 
by the pAb. rFra e 3, by contrast, completely eliminated IgG 
binding to its natural counterpart.
Polymorphism is a common feature of profilin and 
polcalcin allergens and different allergenic capacities have 
been described for distinct isoforms [41]. Remarkably, 
experiments using the pool of sera revealed complete inhibition 
of IgE binding to the natural counterpart allergens in ash 
pollen extract, indicating that rFra e 2 and rFra e 3 contain 
all the major epitopes recognized by the IgEs present in the 
serum of ash pollen–sensitized patients. Analyses of the amino 
acid sequences of profilin in the present study and previously 
reported sequences for profilins from other sources have 
shown a highly variable region involving amino acids 17 to 22. 
This region of the molecule appears to be critical for the cell 
functionality of the protein and for the binding of IgE epitopes 
described to date [42]. Furthermore, it is located at the surface 
of the protein, and thus may constitute a potential interaction 
region for the IgE antibodies of particular allergic patients. The 
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Figure 5. IgE-binding ability of rFra e 2 and rFra e 3. A, Determination of 
IgE binding from individual sera by ELISA. The horizontal line indicates 
the 0.1 cutoff value where sera values were considered positive. B, 
Immunoblotting of 0.5 µg of the recombinant proteins using individual 
sera from patients allergic to Fraxinus excelsior and a nonatopic serum 
(N). C, Inhibition of IgE binding to natural Fra e 2 and Fra e 3 from the 
pollen protein extract of F excelsior using 1 or 5 µg of rFra e 2 and rFra e 3 
as inhibitors. (-), no inhibitor. Arrows indicate the electrophoretic mobility 
of natural Fra e 2 and Fra e 3. Molecular weight markers are shown.
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C-terminal of the protein is the area with the greatest capacity 
to recruit IgEs [43], although this has not been described for 
polcalcin IgE epitopes. The alignment of sequences from 
different sources reveals a region spanning amino acids 4 to 
13 of the N-terminal as the most variable part of the protein. 
These amino acids are not part of the Ca2+-binding site of the 
protein and constitute a very exposed region of the molecule. 
The observed variability in these regions between allergens 
from different sources and even isoforms from the same source 
could account for distinct IgE-binding patterns [41]. 
Comparison of profilin and polcalcin with the corresponding 
members of the Oleaceae family, with which they share the 
greatest phylogenetic similarities, revealed a very high 
degree of sequence identity (2and 5 amino acid changes with 
respect to O europaea profilin and polcalcin, respectively). 
ELISA inhibition experiments revealed equivalent allergenic 
properties in the Oleaceae profilins analyzed, except for that of 
Ligustrum vulgare. Although the profilin sequence of L vulgare 
is unknown, a high level of sequence identity and similarity 
with respect to other Oleaceae counterparts is expected. The 
low level of inhibition observed in the presence of rFra e 2 is 
probably due to the small amounts of natural profilin present in 
the L vulgare pollen extract. On the other hand, food profilins 
showed similar inhibition values, except for L esculentum and 
184
Table. IgE Cross-Reactivity With a Pool of Sera From Patients Allergic to Fra e 2 and Fra e 3 
                                                                  Percentage of Inhibitiona    Accession Number 
  rFra e 2–coated   rFra e 3–coated  (Identity and Similarity, %) 
  wells   wells 
Extract name 20 mg 200 mg 20 mg 200 mg Profilin Polcalcin
Sinapis alba (mustard) 58 59 - - ABU95412.1 (80/89) -
Prunus persica (peach) 9 56 - - Q8GT40 (80/91) -
Solanum tuberosum (potato) 66 66 - - - -
Persea americana (avocado) 66 67 - - - -
Lycopersicon esculentum (tomato) 2 5 - - Q93YG7 (74/85) -
Capsicum annuum (pepper) 58 61 - - Q93YI9 (79/89) -
Brassica oleracea (cauliflower) 54 59 - - - -
Cucumis melo (melon) 63 63 - - Q5FX67 (75/87) -
Pistacia vera (pistachio) 32 63 - - - -
Juglans regia (walnut) 45 64 - - - -
Prunus dulcis (almond) 48 63 - - Q8GSL5 (79/90) -
Arachis hypogea (peanut) 1 12 - - Q9SQI9 (71/85) -
Robinia pseudoacacia (black locust) 61 67 54 69 - -
Fraxinus excelsior (ash) 58 72 83 85 - -
Ligustrum vulgare (common privet) 41 48 74 85 - -
Olea europaea (olive) 66 67 71 81 ABC47412.1 (96/99) O81092 
      (91/97)
Betula verrucosa (birch) 69 69 37 52 P25816 (85/92) Q39419 
      (81/92)
Lolium perenne (perennial ryegrass) 64 66 61 61 - -
Platanus acerifolia (planetree) 61 62 52 85 - -
Salsola kali (Russian thistle) 41 52 45 57 C6JWH0 (76/88) -
Chenopodium album (lamb´s quarter) 40 52 50 56 Q84V37 (75/88) Q84V36 
      (80/93)
Artemisia vulgaris (mugwort) 1 19 18 38 Q8H2C9 (76/88) A0PJ17  
      (61/82)
Parietaria judaica (pellitory) 36 55 56 62 Q9XG85 (76/88) B5QST3  
      (73/85)
Brassica napus (rapeseed) 57 61 52 60 - -
aIgE-binding inhibition (%) to rFra e 2– or rFra e 3–coated wells with 20 or 200 µg (total protein) of indicated extracts as inhibitors. Inhibition results 
with ash pollen extract are highlighted in bold. Accession numbers and identity (%) and similarity (%) of the sequence profilin and polcalcin are 
indicated.
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A hypogea, for which low levels of inhibition were observed, 
possibly due to differences in the highly variable region of 
the profilins or amino acid changes in the full sequence. The 
inhibitory effect of ash pollen polcalcin on Ig binding was 
comparable in all allergenic sources tested except for A vulgaris 
polcalcin, probably due to the phylogenetic distance between 
the 2 sources, which share less sequence identity (61%) and 
similarity (82%) than that found between ash pollen polcalcins 
and those from other sources.
In summary, the present study describes the cloning of the 
main panallergens from F excelsior pollen, their expression 
as recombinant proteins, their purification, and their structural 
and immunological characterization. Both allergens exhibited 
a high degree of sequence identity with homologous proteins 
from related and unrelated sources, as well as similar 
immunological characteristics. Contrary to some previous 
reports [44], recent analyses of profilin have demonstrated 
differences in the IgE-binding ability of profilin isoforms 
from the same Skali pollen source [41]. These differences 
may be even more significant between species and families. 
The availability of these recombinant panallergens could 
facilitate i) the study of the IgE-binding capabilities of critical 
and essential amino acids, ii) the identification of primary 
sensitizers, iii) the clinical diagnosis of polysensitization to 
multiple sources, iv) the standardization of allergen extracts 
used in immunotherapy, and v) personalized desensitization 
of sensitized patients.
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